Erratum to ‘Forgotten antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia’: (International Journal of Antimicrobial Agents (2017) 49(1) (98–101) (S0924857916303363) (10.1016/j.ijantimicag.2016.09.029);Forgotten antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia

International Journal of Antimicrobial Agents

Volumn 49, Issue 1, 2017, Pages 98-101

  Pulcini, Céline ^a   Mohrs, Simone ^b   Beovic, Bojana ^c   Gyssens, Inge ^d,e   Theuretzbacher, Ursula ^f   Cars, Otto ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HASSELT UNIVERSITY   (Belgium)

^f Center For Anti Infective Agents Vienna   (Austria)

Author keywords

Antibiotic stewardship; Bacterial resistance; Drug approval; Drug marketing

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BENZATHINE PENICILLIN; CEFOPERAZONE PLUS SULBACTAM; CEFOXITIN; CEFPODOXIME; CEFTIBUTEN; CHLORAMPHENICOL; CLOXACILLIN; COLISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; DICLOXACILLIN; FLUCLOXACILLIN; FOSFOMYCIN; FUSIDIC ACID; MECILLINAM; METHENAMINE HIPPURATE; METHENAMINE MANDELATE; NAFCILLIN; OXACILLIN; PIVMECILLINAM; POLYMYXIN B; PRISTINAMYCIN; PROCAINE PENICILLIN; SPECTINOMYCIN; SULTAMICILLIN; TEMOCILLIN; THIAMPHENICOL; TIMENTIN; UNINDEXED DRUG; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; CANADA; DRUG MARKETING; DRUG USE; ESTONIA; EUROPE; FOLLOW UP; FRANCE; INFECTION; PRIORITY JOURNAL; UNITED STATES; DEVICES; HUMAN; QUESTIONNAIRE; SUPPLY AND DISTRIBUTION;

ANTI-BACTERIAL AGENTS; AUSTRALIA; CANADA; EQUIPMENT AND SUPPLIES; EUROPE; HUMANS; SURVEYS AND QUESTIONNAIRES; UNITED STATES;

EID: 85006924997     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2017.02.006     Document Type: Erratum

References (9)

1. [1] World Health Organization, Global action plan on antimicrobial resistance. 2015, WHO Available from http://www.who.int/topics/antimicrobial_resistance/en/ [Accessed 1 August 2016].
2. [2] Ardal, C., Outterson, K., Hoffman, S.J., Ghafur, A., Sharland, M., Ranganathan, N., et al. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet 387 (2016), 296–307.
3. [3] Hoffman, S.J., Outterson, K., Rottingen, J.A., Cars, O., Clift, C., Rizvi, Z., et al. An international legal framework to address antimicrobial resistance. Bull World Health Organ, 93, 2015, 66.
4. [4] Pulcini, C., Bush, K., Craig, W.A., Frimodt-Møller, N., Grayson, M.L., Mouton, J.W., et al. Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia. Clin Infect Dis 54 (2012), 268–274.
5. [5] Cassir, N., Rolain, J.M., Brouqui, P., A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol, 5, 2014, 551.
6. [6] Muller, A.E., Theuretzbacher, U., Mouton, J.W., Use of old antibiotics now and in the future from a pharmacokinetic/pharmacodynamic perspective. Clin Microbiol Infect 21 (2015), 881–885.
7. [7] Review on Antimicrobial Resistance, Tackling drug-resistant infections globally: final reports and recommendations. 2016, Review on Antimicrobial Resistance Available from http://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf [Accessed 1 August 2016].
8. [8] Council of the European Union, Council conclusions on the next steps under a One Health approach to combat antimicrobial resistance. 2016, Council of the European Union Available from http://www.consilium.europa.eu/en/press/press-releases/2016/06/17-epsco-conclusions-antimicrobial-resistance/ [Accessed 1 August 2016].
9. [9] European Commission, Explanatory note on the Joint Procurement Mechanism. 2015, European Commission, Luxembourg Available from http://ec.europa.eu/health/preparedness_response/docs/jpa_explanatory_en.pdf [Accessed 1 August 2016].